Chaperonin Protein CCT2 Emerges as Key Driver of Aggressive Head and Neck Cancer and Cisplatin Resistance
New research shows that the chaperonin subunit CCT2 stabilizes the oncoprotein c-Myc to drive head and neck squamous cell carcinoma ...
New research shows that the chaperonin subunit CCT2 stabilizes the oncoprotein c-Myc to drive head and neck squamous cell carcinoma ...
A machine learning analysis of 1,525 SEER records finds that concurrent chemoradiotherapy is associated with roughly 30 percent better disease-specific ...
Spanish researchers have identified a ten-bacteria salivary signature that independently predicts survival and recurrence risk in head and neck squamous ...
New research shows that CBP-driven histone H3K18 lactylation activates GLI2 transcription, promoting head and neck squamous cell carcinoma progression and ...
A new review argues that malnutrition in head and neck cancer is driven by tumor metabolism and chronic inflammation rather ...
A multi-omics study finds that LDL cholesterol metabolism reshapes macrophages and tumor cells in head and neck squamous cell carcinoma, ...
Researchers have introduced the Spatial Immune Barrier Index, a spatial transcriptomics measure that quantifies the suppressive barrier holding immune cells ...
Researchers in Düsseldorf report that co-expressing a non-signaling EGFR-binding CAR alongside EGFRvIII-specific CAR T-cells enhances killing of head and neck ...
New research links the SERPINE1–CA9 gene axis to both aggressive growth and cisplatin resistance in head and neck squamous cell ...
Researchers in Leipzig corrected a hidden error in a Bayesian network and found the transparent AI model matched real tumor ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine